Enhanced Recovery After Bilateral Reduction Mammaplasty

Not Applicable

Terminated

Brief Summary: This single-center, clinical trial is being conducted to determine whether non-narcotic pain regiments are as effective as narcotic-based regiments in reducing post-operative pain in patients undergoing breast reduction in the outpatient setting.

Detailed Description: This is a non-blinded, non-inferiority, randomized control trial with the primary outcome of interest being overall pain, with secondary outcomes including adverse effects from pain medications, patient satisfaction with their pain regiment and with their surgery, and the impact of pain on their daily activities. This study is designed to follow one-hundred (100) qualified and consenting patients seeing the PI/surgeon (JMK) at his office at UT Southwestern for their initial operative consultation for macromastia. If patients meet eligibility criteria, they will be offered enrollment in the trial.

Recruitment & Eligibility

Inclusion Criteria

patients undergoing bilateral breast reduction (reduction mammaplasty) with the PI in the outpatient setting
Age 18 and older
BMI less than 40, non-smokers.

Exclusion Criteria

age less than 18,
BMI over 40,
smokers,
uncontrolled diabetes,
American Society of Anesthesiologists (ASA) status scores 3 or higher
patients with allergies to any of the medications in the ERAS or current practice regiments (gabapentin, celecoxib, ketorolac, ondansetron, or hydrocodone).
History of narcotic or IV drug abuse
History of chronic pain
Hypersensitivity or allergy to any of these drugs: gabapentin, celecoxib, ketorolac, hydrocodone, ibuprofen or acetaminophen
Current pregnancy or planning pregnancy in the next xx weeks/ months
Contraindications to NSAID drugs (ketorolac, ibuprofen, celecoxib): coagulation disorder, active bleeding, severe renal impairment, hepatic impairment.
Contraindications to gabapentin: caution for CrCl <60, caution in elderly, caution if alcohol consumption
Contraindications to acetaminophen: hepatic or renal impairment, chronic alcohol use

Arm && Interventions

Group	Intervention	Description
Current Practice Arm	Macromastia	The current practice arm will include: post-operatively, hydrocodone-acetaminophen 5/325mg tabs and ibuprofen 800mg, as needed for pain. Additionally, acetaminophen may be used in conjunction with the above regiment. Ibuprofen and acetaminophen can be taken as needed or alternating every 6 hours, scheduled.
Enhanced Recovery After Surgery (ERAS) Arm	Macromastia	ERAS Arm will undergo multimodal regiment: Before Surgery- gabepentin 300mg and celecoxib 400mg once the day before surgery and again 3 hours prior to surgery. During surgery- subjects will receive ketorolac 30mg IV ketorolac once (15mg for patients age 64 years and above). Post-operatively- Gabapentin 100mg three times daily for POD0-7, ketorolac 10mg four times daily for POD1-5 days, and ondansetron 4mg as needed for nausea; patients will also have a prescription for hydrocodone-acetaminophen 5/325mg tabs that they may fill if needed for emergency/breakthrough pain.

Primary Outcome Measures

Name	Time	Method
Post-operative Pain Questionnaire	Day 0 - Day 7	Determine the efficacy of non-narcotic pain regiments in patients undergoing breast reduction surgery and compare it to narcotic-based pain regiments in improving post-operative pain in patients undergoing breast reduction surgery. Patients will be asked to rate their pain from a scale of 0 ("No Pain") to 10 ("Pain as bad as you can imagine").

Secondary Outcome Measures

Name	Time	Method
Post operative Patient Satisfaction Questionnaire: Postoperative Module Satisfaction with Information Survey	Day 0- Day 7	The following questionnaires will be used to track the patients satisfaction following their procedure: BREAST- Q Postoperative Reconstruction Module Satisfaction with Information Survey. Patients will be asked to rate their satisfaction with: Very dissatisfied, Somewhat dissatisfied, Somewhat satisfied or very satisfied.
Post operative Quality of Life Questionnaire	Day 0- Day 7	The following questionnaires will be used to track the patients satisfaction following their procedure. The postoperative questions do not have an applicable scale.
Post operative Patient Satisfaction Questionnaire: Postoperative Reduction Module Satisfaction with Outcome	Day 0- Day 7	The following questionnaires will be used to track the patients satisfaction following their procedure: BREAST-Q Postoperative Reduction Module Satisfaction with Outcome. Patients will be asked to rate their satisfaction with: Very dissatisfied, Somewhat dissatisfied, Somewhat satisfied or very satisfied.

Locations (1): University of Texas Southwestern Medical Center
🇺🇸
Dallas, Texas, United States